Genesis Global Group
Integrated Analytical Solutions, Inc.

You will now be redirected to the GD3 website

Integrated Analytical Solutions, Inc. is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3


Drug-Drug Interaction (DDI) Assays

Understanding compound interactions with co-dosed medications is critical to the drug development and market approval process. IAS provides DDI data to steer you toward drug candidates with reduced potential for adverse events and toxicity.

CYP450 Inhibition Studies

  • IC50 Determination
  • Single Point Inhibition Studies
Drug-Drug Interaction (DDI) Assays Illustration